Polen Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-93,546
Closed -$2.47M 69
2020
Q2
$2.47M Buy
93,546
+26,974
+41% +$705K 0.01% 58
2020
Q1
$1.66M Buy
66,572
+26,684
+67% +$824K 0.01% 43
2019
Q4
$1.43M Buy
39,888
+10,552
+36% +$364K 0.01% 41
2019
Q3
$1M Buy
29,336
+455
+2% +$14.5K ﹤0.01% 40
2019
Q2
$808K Buy
28,881
+2,016
+8% +$56K ﹤0.01% 47
2019
Q1
$833K Buy
26,865
+2,131
+9% +$56.9K ﹤0.01% 47
2018
Q4
$585K Buy
24,734
+11,551
+88% +$315K ﹤0.01% 48
2018
Q3
$511K Buy
13,183
+3,334
+34% +$120K ﹤0.01% 45
2018
Q2
$330K Buy
9,849
+1,941
+25% +$69.1K ﹤0.01% 52
2018
Q1
$287K Buy
+7,908
New +$274K ﹤0.01% 51

Other funds holding LMAT

Polen Capital Management's LMAT Position: Q3 2020 in Review

Polen Capital Management sold out of LeMaitre Vascular (LMAT) in Q3 2020, closing a stake of 93,546 shares — an estimated $2.47M sold.

Polen Capital Management first reported a position in LMAT in Q1 2018 and held it in 10 quarters. The position peaked at $2.47M in Q2 2020. 141 funds tracked by Wall St. Rank hold LMAT as of Q3 2020.

  • Polen Capital Management reported no remaining LeMaitre Vascular position as of Q3 2020 after selling out during the quarter.
  • Polen Capital Management sold 93,546 LeMaitre Vascular shares in Q3 2020, an estimated $2.47M.
  • Polen Capital Management first reported a position in LeMaitre Vascular in Q1 2018 and held it in 10 quarters.
  • Polen Capital Management's LeMaitre Vascular position peaked at $2.47M in Q2 2020.
  • 141 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2020.

Based on Polen Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.